Real-time enrollment status for this chronic kidney disease and hypertension clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:52 AM UTC
| NCT Number | NCT07222917 |
| Recruiting Status | Recruiting |
| Condition | Chronic Kidney Disease and Hypertension |
| Phase | Clinical Trial |
| Target Enrollment | 218 participants |
| Active Locations | 18 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | May 18, 2026 (May 18, 2026) |
As of July 13, 2026: Clinical trial NCT07222917 is currently recruiting participants. This clinical trial study for chronic kidney disease and hypertension is actively seeking new participants at 18 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07222917 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07222917 was last updated May 18, 2026 (May 18, 2026). HelloStudys verifies this status automatically.